missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30172008

GIT1 Antibody (924640) [Janelia Fluor™ 669], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB8508JF669

Product Code. 30172008

  • 5380.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

GIT1 Monoclonal antibody specifically detects GIT1 in Human,Mouse,Rat samples. It is validated for ELISA,Immunohistochemistry,Western Blot,Flow Cytometry (Intracellular Staining),CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

GIT1
Monoclonal
Janelia Fluor 669
ARF GAP GIT1, ARF GTPase-activating protein GIT1, CAT1, CAT-1, Cool-associated and tyrosine-phosphorylated protein 1, G protein-coupled receptor kinase interacting ArfGAP 1, G protein-coupled receptor kinase interactor 1, G protein-coupled receptor kinase-interactor 1, GRK-interacting protein 1
E. coli-derived recombinant human GIT1, Ser485-Asp636, Accession # Q9Y2X7
RUO
Primary
Human, Mouse, Rat
Liquid
ELISA, Immunohistochemistry, Western Blot, Flow Cytometry (Intracellular Staining), CyTOF
924640
50mM Sodium Borate
Mouse
0.1 mL
Cell Biology, Cytoskeleton Markers, GPCR, Signal Transduction
28964
Store at 4°C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.